Company: BIVIW
Filing Date: 2025-11-13
Form Type: 8-K
Source: 0001520138-25-000352
Chunk: 0

Company: BIOVIE INC.
Filing Date: 2025-11-13
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                                                                                           
         10.1      BioVie Inc. 2019 Omnibus Equity Incentive Plan (Amended and Restated through November 10, 2025) (incorporated by reference to Appendix A to the Definitive Proxy Statement on Schedule 14A, filed...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the inline XBRL document)                                                                                                                           

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

  BioVie INC.                                                         
  By:              /s/ Joanne Wendy Kim                               
                   Name:                     Joanne Wendy Kim         
                   Title:                    Chief Financial Officer